Cyclacel Pharmaceuticals, Inc. Uncategorized Contracts & Agreements

82 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Lock-Up Addendum, dated February 20, 2025, by and between the Company and David Lazar
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2025
Amendment Agreement, dated as of February 4, 2025, between the Company and Armistice Capital Master Fund Ltd
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2025
Description of Securities
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2024
Description of Securities
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2023
Extension Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron, effective as of January 1, 2023
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2022
Extension Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis, effective as of January 1, 2023
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2022
Description of Securities
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2022
Description of Securities
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2021
CYCLACEL PHARMACEUTICALS, INC. 200 Connell Drive, Suite 1500 Berkeley Heights, NJ 07922 June 27, 2017
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2017
CYCLACEL PHARMACEUTICALS, INC. 200 Connell Drive, Suite 1500 Berkeley Heights, NJ 07922 June 27, 2017
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2017
CYCLACEL PHARMACEUTICALS, INC. 200 Connell Drive, Suite 1500 Berkeley Heights, NJ 07922 December 22, 2016
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2017
CYCLACEL PHARMACEUTICALS, INC. 200 Connell Drive, Suite 1500 Berkeley Heights, NJ 07922 December 22, 2016
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2017
SECURITIESPURCHASE AGREEMENT
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2015
430 Park Avenue | New York,New York 10022 | 212 ###-###-#### | www.hcwco.com Member: FINRA/SIPC
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2015
EMPLOYMENTAGREEMENT
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NJ
2014
EX-101 INSTANCE DOCUMENT
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2011
EX-101 INSTANCE DOCUMENT
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2011
consolidated balance sheets as of March 31, 2009, June 30, 2009, September 30, 2009, December 31, 2009, March 31, 2010, June 30, 2010, and September 30, 2010 and statement of...
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NJ
2011
consolidated balance sheets as of March 31, 2009, June 30, 2009, September 30, 2009, December 31, 2009, March 31, 2010, June 30, 2010, and September 30, 2010 and statement of...
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NJ
2011
2,350,000 Units CYCLACEL PHARMACEUTICALS, INC. PLACEMENT AGENT AGREEMENT
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2010
2,850,000 Units
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2010
Financial Statements
Cyclacel Pharmaceuticals, Inc.
Biotechnology
DE
2009
Financial Statements
Cyclacel Pharmaceuticals, Inc.
Biotechnology
DE
2009
CYCLACEL PHARMACEUTICALS, INC.
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2009
CYCLACEL PHARMACEUTICALS, INC.
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2009
4,000,000 Units
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2009
200 Connell Drive, #1600, Berkeley Heights, New Jersey, 07922, USA Tel -1 ###-###-#### Fax -1 ###-###-####
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2007
4,249,668Units CYCLACEL PHARMACEUTICALS,INC. PLACEMENT AGENTAGREEMENT
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2007
SUBSCRIPTIONAGREEMENT
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2007
DATED , 2006
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2006
AGREEMENT
Cyclacel Pharmaceuticals, Inc.
Biotechnology
WA
2005
- 2 -
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2005
XCYTE THERAPIES, INC.
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2005
XCYTE THERAPIES, INC.
Cyclacel Pharmaceuticals, Inc.
Biotechnology
DE
2005
XCYTE THERAPIES, INC.
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2004
XCYTE THERAPIES, INC.
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2004
INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2004
XCYTE THERAPIES, INC. 1,500,000 Shares
Cyclacel Pharmaceuticals, Inc.
Biotechnology
NY
2004
AMENDMENT NO. 5
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2004
AMENDMENT NO. 7
Cyclacel Pharmaceuticals, Inc.
Biotechnology
2004